ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2009

Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.

Paul J Kostenuik et al.PubMed ↗Publisher ↗

No numbers read from the abstract.